Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

lobal, Pipeline by Phase (%), 2009 1

Figure 2: Gastrointestinal Disorder Therapeutics Market, Global, Licensing Agreements Split by Phase (%), 1998-2010 2

Figure 3: Gastrointestinal Disorder Therapeutics Market, Global, Revenue ($m), 2001-2016 14

Figure 4: Gastrointestinal Disorder Therapeutics Market, Global, Annual Cost of Treatment, 2001-2016 15

Figure 5: Gastrointestinal Disorder Therapeutics Market, Global, Diseased Population, 2001-2016 16

Figure 6: Gastrointestinal Disorder Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 17

Figure 7: Gastrointestinal Disorder Therapeutics Market, Global, Diagnosis Population, 2001-2016 18

Figure 8: Gastrointestinal Disorder Therapeutics Market, Global, Prescription Population, 2001-2016 19

Figure 9: Gastrointestinal Disorder Therapeutics Market, Global, Usage Patterns, 2001-2016 20

Figure 10: Gastrointestinal Disorder Therapeutics Market, Global, Geographical Distribution of Revenues ($bn), 2001-2016 21

Figure 11: Gastrointestinal Disorder Therapeutics Market, The US, Revenue ($m), 2001-2016 22

Figure 12: Gastrointestinal Disorder Therapeutics Market, The US, Annual Cost of Treatment, 2001-2016 23

Figure 13: Gastrointestinal Disorder Therapeutics Market, The US, Diseased Population, 2001-2016 24

Figure 14: Gastrointestinal Disorder Therapeutics Market, The US, Treatment Seeking Population, 2001-2016 25

Figure 15: Gastrointestinal Disorder Therapeutics Market, The US, Diagnosis Population, 2001-201
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... report to their offering. This report ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Asia-Pacific , and Rest of ... 2012 through 2020. Market data and analytics are derived from ...
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
(Date:8/18/2014)... Dallas, Texas (PRWEB) August 19, 2014 ... China Linalool Industryā€¯ is a professional and in-depth ... report provides basic Linalool information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, ... company developing medical countermeasures against biological and chemical threats, ... quarter of 2009 will be released on Thursday, May ... to discuss its first quarter 2009 financial results. ...
... fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq: ... has signed a contract with the City of Baltimore, Maryland,("the ... for boiler applications in the heart of Baltimore. This is ... non fossil fuel in its industrial boilers. In this program, ...
... May 7 Covance Inc. (NYSE: CVD ... its board of directors. Mr. McCartney currently serves as ... provider of specialty products, services, and supply chain solutions. ... of U.S. Robotics (USR), a multibillion dollar provider of ...
Cached Biology Technology:City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications 2City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications 3Covance Elects John McCartney to Company's Board of Directors 2
(Date:8/19/2014)... Plants are superior to humans and animals in a ... regenerate, which enables them to regrow entire organs. After ... grow back its entire crown. But there is one ... quite literally rooted to the habitats in which they ... elements. In response to this dilemma, plants have developed ...
(Date:8/19/2014)... to treat pain, but its effect on pain ... a recent study reported on the Neural ... rat models of an avulsion injury to the ... neuropathic pain) were given electroacupuncture stimulation at bilateral ... (GB34). After electroacupuncture therapy, chronic neuropathic pain in ...
(Date:8/19/2014)... news release is available in German . ... get new information about the metabolism of plants can ... However, Erich Kombrink from the Max Planck Institute for ... the University of Duisburg-Essen adopt a different approach. They ... metabolic process like brake pads and prevent the downstream ...
Breaking Biology News(10 mins):How steroid hormones enable plants to grow 2Researchers block plant hormone 2Researchers block plant hormone 3
... cases of Marburg haemorrhagic fever have been reported in ... reported its first 6 cases, bringing the number of ... part of the country. , Mobile surveillance teams in ... were attacked and damaged by local residents. As the ...
... provide a method of quantifying the expression and order of ... measure of cell physiology, said researchers at Baylor College of ... journal Nature Genetics. , "Microarray data are good phenotypes to ... measure of cell status," said Dr. Gad Shaulsky, associate professor ...
... administration to improve patient compliance and reduce drug side ... healthcare product category. While quietly gaining market share for ... and HRT, the technology is set to make further ... conditions wind their way through the development and clinical ...
Cached Biology News:WHO suspends Marburg work, appeals for new funds 2Microarrays as phenotype 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
MDMA Mouse Monoclonal Antibody (Clone 3G8)...
Biology Products: